Invesco S&P SmallCap Health Care ETF Rating → Protect Your Bank Account from China (From Behind the Markets) (Ad) Free PSCH Stock Alerts $41.79 -0.08 (-0.19%) (As of 06/17/2024 ET) Add Compare Share Share RatingsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrends Invesco S&P SmallCap Health Care ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PSCH Aggregate RatingModerate Buy2.69Holdings in PSCH have an aggregate rating of Moderate Buy based on 321 analyst ratings issued in the past year covering 47 companies (88.6% of the portfolio).PSCH Aggregate Price Target$54.2429.80% UpsideHigh Prediction$70.25Average Prediction$54.24Low Prediction$42.07Holdings in PSCH have an aggregate price target of $54.24 and a range of $42.07 to $70.25 covering 47 companies (88.6% of the portfolio).PSCH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy12 Buy rating(s)Moderate Buy25 Moderate Buy rating(s)Hold10 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco S&P SmallCap Health Care ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 47 PSCH Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.82%ENSGThe Ensign Group$122.15+2.7%4 of 5 stars2.80$124.60 2.0%5Dividend AnnouncementShort Interest ↓Positive News4.78%GKOSGlaukos$111.99-0.5%3 of 5 stars2.82$112.27 0.3%114.54%OGNOrganon & Co.$20.34-0.3%5 of 5 stars2.50$22.60 11.1%4Positive News4.11%MMSIMerit Medical Systems$80.71-1.3%4 of 5 stars2.89$92.78 15.0%9Positive News3.56%ALKSAlkermes$25.01+2.1%5 of 5 stars2.55$36.50 45.9%11Analyst ForecastShort Interest ↓Positive News3.37%ITGRInteger$117.40+0.9%2 of 5 stars2.71$128.00 9.0%73.32%RDNTRadNet$58.50+0.1%3 of 5 stars2.75$57.25 -2.1%43.09%SEMSelect Medical$34.22+1.2%4 of 5 stars2.50$34.25 0.1%4Positive News2.78%PBHPrestige Consumer Healthcare$64.86+0.9%4 of 5 stars2.50$91.25 40.7%42.57%TNDMTandem Diabetes Care$43.00-5.1%4 of 5 stars2.92$51.25 19.2%13Positive News2.29%CORTCorcept Therapeutics$28.59-1.3%5 of 5 stars3.00$44.30 54.9%4Analyst Forecast2.02%NARIInari Medical$43.23-4.6%4 of 5 stars2.71$65.71 52.0%72.01%ICUIICU Medical$118.51+4.3%3 of 5 stars3.00$127.00 7.2%3Analyst UpgradePositive News1.92%PINCPremier$18.10-1.5%4 of 5 stars2.00$23.50 29.8%121.90%CNMDCONMED$70.38-1.0%5 of 5 stars2.83$102.50 45.6%6Insider SellingShort Interest ↑Positive News1.85%FTREFortrea$24.06+0.4%3 of 5 stars2.50$32.30 34.2%121.82%AMNAMN Healthcare Services$53.91-2.5%5 of 5 stars2.50$75.57 40.2%81.79%MYGNMyriad Genetics$24.03+3.6%2 of 5 stars2.33$24.88 3.5%9Gap Up1.76%VCELVericel$41.71-1.4%1 of 5 stars3.00$46.80 12.2%6Positive News1.75%STAASTAAR Surgical$40.08-2.8%5 of 5 stars2.45$47.00 17.3%11Positive NewsGap Up1.62%ADUSAddus HomeCare$117.70+1.1%5 of 5 stars2.75$112.14 -4.7%8Short Interest ↓1.62%PDCOPatterson Companies$22.85+1.0%4 of 5 stars2.33$31.67 38.6%9Dividend AnnouncementHigh Trading Volume1.56%PRVAPrivia Health Group$17.30-1.0%5 of 5 stars2.93$24.92 44.1%14Positive News1.54%UFPTUFP Technologies$250.92-0.3%1 of 5 stars2.50$238.50 -4.9%2Positive News1.46%NEONeoGenomics$13.10-0.6%3 of 5 stars2.90$19.78 51.0%101.46%CPRXCatalyst Pharmaceuticals$15.00-0.4%5 of 5 stars3.00$26.71 78.1%5Short Interest ↓Positive News1.45%ASTHAstrana Health$40.00+1.3%2 of 5 stars3.00$48.25 20.6%51.39%CERTCertara$14.37-3.5%5 of 5 stars2.36$20.06 39.6%11Short Interest ↓1.38%LMATLeMaitre Vascular$81.38+1.6%4 of 5 stars2.89$77.57 -4.7%9Positive News1.32%AMPHAmphastar Pharmaceuticals$40.54+0.1%5 of 5 stars2.50$66.00 62.8%4Positive News1.30%DVAXDynavax Technologies$11.34-1.8%4 of 5 stars2.75$25.33 123.4%4Short Interest ↓Positive News1.24%SUPNSupernus Pharmaceuticals$25.994 of 5 stars3.00$41.00 57.8%1Positive News1.23%USPHU.S. Physical Therapy$96.28+1.9%4 of 5 stars3.00$125.67 30.5%4Positive News1.14%LGNDLigand Pharmaceuticals$80.64+0.7%5 of 5 stars3.00$116.33 44.3%3Short Interest ↓Positive News1.14%PCRXPacira BioSciences$27.34-2.8%5 of 5 stars3.00$47.40 73.4%10Positive News1.11%OMIOwens & Minor$16.98+1.7%4 of 5 stars2.00$23.29 37.1%81.10%OMCLOmnicell$27.913 of 5 stars2.33$42.20 51.2%6Positive News1.09%XNCRXencor$19.52-5.2%4 of 5 stars3.00$35.38 81.2%8Positive News0.98%SDGRSchrödinger$19.89-3.6%1 of 5 stars2.67$40.89 105.6%90.90%COLLCollegium Pharmaceutical$31.82+0.2%4 of 5 stars2.40$40.75 28.1%5Positive News0.83%HRMYHarmony Biosciences$29.37+1.1%4 of 5 stars2.50$40.63 38.3%8Positive News0.82%ANIPANI Pharmaceuticals$61.78-1.3%5 of 5 stars3.00$81.00 31.1%40.81%AHCOAdaptHealth$11.28-0.4%2 of 5 stars2.40$12.42 10.1%50.80%RCUSArcus Biosciences$16.20-4.5%2 of 5 stars2.88$40.50 150.0%80.79%AORTArtivion$23.17+0.2%1 of 5 stars3.00$27.50 18.7%20.78%AVNSAvanos Medical$18.95-1.5%0 of 5 stars2.002Gap Up0.73%VIRVir Biotechnology$9.18-5.8%2 of 5 stars2.57$34.14 271.9%7Gap DownHigh Trading Volume This page (NASDAQ:PSCH) was last updated on 6/18/2024 by MarketBeat.com Staff From Our PartnersBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredBeta testers blew this thing upThis AI trading tool is probably unlike anything you've ever seen before… It scans the entire market and fi...Prosper Trading Academy | SponsoredRadical change coming — do this NOW to protect yourselfI recently uncovered a way the government could use the next crisis as a pretext to gain more control … and ra...Weiss Ratings | SponsoredUnexpected twist to Trump’s trialUnexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...Stansberry Research | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredInflation Is Robbing You Blind! Here’s How to Fight Back!Quietly, inflation has reduced your purchasing power by 29.4% since 2014. So something that cost $100 in 20...American Alternative | SponsoredElon Musk: THIS will be bigger than TeslaIf you missed out on crypto, this could be your second chance. The AI “wealth window” is opening now, but you ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco S&P SmallCap Health Care ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco S&P SmallCap Health Care ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.